• September 4, 2022
• 0

Rheumatoid arthritis, neonatal-onset multisystem inflammatory illness, and interleukin-1 receptor antagonist deficiency are all treated with the human interleukin-1 receptor antagonist recombinant drug anakinra. IL-1 alpha and beta activity are inhibited...